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A previous communication from this laboratory described the pyridine 
nucleotide-dependent reduction of the a-keto acid analogue of lysine to 
L-pipecolic acid catalyzed by preparations of mammalian liver (1). The 
reaction proceeded with either DPNHr or TPNH and the enzyme prep- 
aration obtained from rat liver also catalyzed reduction of the a-keto acid 
analogue of ornithine and of glutamic acid-y-semialdehyde to proline. 
a-Keto-a-aminocaproic acid, the a-keto acid analogue of lysine, exists in 
solution in equilibrium with the cyclic form Al-piperidine-2-carboxylic 
acid (2); previous findings also indicate that a-keto-&aminovaleric acid 
(2) and glutamic acid-r-semialdehyde (3) exist in equilibrium with A’- 
pyrroline-2-carboxylic acid and A’-pyrroline-5-carboxylic acid, respectively. 
The present report describes further experimental work on the enzyme 
system that catalyzes the formation of L-pipecolic acid (from Al-piperidine- 
2-carboxylic acid) and L-proline (from A’-pyrroline-2-carboxylic acid). 
This activity has been found in several animal and plant tissues, and a 
purified preparation of the enzyme has been obtained from rat kidney; 
studies with this preparation and other data indicate that Al-pyrrolined- 
carboxylic acid and A’-pyrroline-2-carboxylic acid are reduced to L-proline 
by different enzymes. On the other hand, both Al-pyrroline-2-carboxylic 
acid and A’-piperidine-2-carboxylic acid appear to be reduced by the same 
enzyme. The available evidence suggests that A’-piperidine-2-carboxylic 
acid is an intermediate in the conversion of lysine to pipecolic acid. The 
role of A*-pyrroline-2-carboxylic acid in proline metabolism will be dis- 
cussed. 
* This investigation was supported in part by grants from the National Science 
Foundation, the National Heart Institute, National Institutes of Health, United 
States Public Health Service, and E. I. du Pont de Nemours and Company. 
t Traveling scholar of the J. N. Tata Endowment, India. 
i Abbreviations are aa follows: Ai-piperidine-2-carboxylic acid, PIP-2-CA; A*-pyr- 
roline-2-carboxylic acid, PYR-P-CA; Ai-pyrroline-5-carboxylic acid, PYR-5-CA; re- 
duced diphosphopyridine nucleotide, DPNH; reduced triphosphopyridine nucleotide, 
TPNH; flavin adenine dinucleotide, FAD. 
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790 L-PIPECOLIC ACID AND L-PROLINE 
EXPERIMENTAL 
Materials-PIP-2-CA and PYR-2-CA were prepared as the hydrobro- 
mides from the corresponding N-carhobenzyloxy derivatives as previously 
described (2). The cr-keto acids were dissolved in potassium bicarbonate 
solution immediately before being used. PYRd-CA was prepared by 
boiling y ,-r-dicarbethoxyr-acetamidobutryaldehyde (4) under a reflux 
with 6 N hydrochloric acid (3). 
DPNH was prepared from purified DPN as previously described (5), 
and enzymatically prepared DPNH was obtained from the Sigma Chemical 
Company; no significant differences were observed in our studies between 
the two DPNH preparations. TPNH was prepared from TPN (Sigma) 
by reduction with d-isocitrate and isocitric dehydrogenase (5). d-lsoci- 
trate was obtained by alkaline hydrolysis of l-dimethylisocitrate lactone 
isolated from Bryophyllum calycinum leaves (6). When TPNH prepared 
by reduction with hydrosulfite (obtained from Sigma) was used, enzymatic 
reduction of PIP-2-CA and PYR-S-CA took place at about 20 per cent of 
the corresponding rates with TPNH prepared from Sigma TPN enzymatic- 
ally. Studies in which Sigma TPNH was added to DPNH suggested that 
the TPNH prepared with hydrosulfite inhibited the reaction. Enzymat- 
ically prepared TPNH was therefore employed in the present studies. 
Pyrrole-2-carboxylic acid and Al-pyrroline-4-hydroxy-2-carboxylic acid 
were obtained as described (7); picolinic acid was a product of the East- 
man Kodak Company. 
Enzyme Preparations 
Rat Kidney-10 gm. of fresh kidney were homogenized in a Potter- 
Elvehjem homogenizer with 30 ml. of ice-cold 0.1 M potassium phosphate 
buffer, pH 7.0, and the homogenate was centrifuged in a Spinco model L 
centrifuge at 144,000 X g at 2“ for 2 hours. The clear supernatant solution 
was decanted and brought successively (at 5”) to 30,40,50, and 60 per cent 
of saturation with respect to ammonium sulfate by the addition of a satu- 
rated solution of ammonium sulfate adjusted to pH 7.0 with ammonium 
hydroxide. The precipitates obtained at 40 and 50 per cent of saturation 
were combined and dissolved in 10 ml. of cold 0.05 M potassium phosphate 
buffer, pH 7.0, and dialyzed for 12 hours at 5” against 20 volumes of the 
same buffer. A small inactive precipitate was removed by centrifugation 
and 0.45 ml. of calcium phosphate gel (100 mg. of dry weight per ml.) 
was added per ml. of dialyzed solution. The mixture was shaken gently 
at 26’ for 30 minutes. After removal of the gel by centrifugation, the 
supernatant solution was lyophilized. 
Rat Liver-The rat liver preparation was obtained by a procedure similar 
to that employed for rat kidney. The supernatant solution obtained by 
 by guest, on M
arch 14, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
MEISTEII, ItAI)HAKItISHNAN, AND BUCKLEY 791 
centrifugation at 144,000 X g was fractionated with ammonium sulfate 
and the precipitate obtained between 43 and 55 per cent of saturation was 
dissolved in buffer, dialyzed, and heated at 50” for 20 minutes. The solu- 
tion was cooled rapidly in ice and the precipitated protein was removed by 
centrifugation. The clear supernatant solution was lyophilized. 
Neurospora-A mutant strain of Neurospora crassa known to be blocked 
in the biosynthesis of proline between PYRd-CA and proline (strain 
21863a) and the corresponding parent wild strain (strain 74a (8))l were 
grown on the Fries medium (9) containing 0.02 per cent n-proline. After 
incubation at 30” for 3 days, the mycelium was harvested, washed with 
distilled water, and frozen with dry ice. The frozen mycelium was treated 
with 5 volumes of ice-cold acetone in a Waring blendor for 3 minutes and 
the resulting homogenate was filtered rapidly; the acetone-insoluble 
material was placed in a vacuum desiccator over phosphorus pentoxide 
at 5O for 18 hours. The acetone powders were ground in a mortar with 3 
parts (by weight) of Alumina A-301 (Aluminum Company of America) 
and the mixture was then homogenized in a Potter-Elvehjem homogenizer 
with 10 volumes of 0.1 M potassium phosphate buffer, pH 7.0, at 5”. The 
homogenates were centrifuged in a Spinco model L ultracentrifuge at 
144,000 X g for 45 minutes at 2” and the resulting clear supernatant solu- 
tions were fractionated with ammonium sulfate. Solid ammonium sulfate 
(17.5 gm. per 100 ml. of supernatant solution) was added rapidly at 5” 
and the solution was allowed to stand at this temperature for 30 minutes. 
The resulting precipitate was removed by centrifugation and dissolved in 
the minimal quantity of 0.1 M potassium phosphate buffer, pH 7.0. The 
preparation was dialyzed against the same buffer at 5’ for 18 hours before 
use. The mutant and wild strain preparations were processed at the same 
time in identical fashion. 
Plants-Phaseolus radiatus and Pisum sativum seeds were germinated 
in the dark for 48 hours. The germinated seeds were homogenized with 
20 volumes of ice-cold acetone in a Waring blendor and the mixture was 
filtered rapidly. The acetone-dried material was extracted with 5 volumes 
of cold 0.1 M potassium phosphate buffer, pH 7.0, in a Potter-Elvehjem 
homogenizer and the homogenates were centrifuged for 15 minutes at 
300 x g. 
Methods-Pipecolic acid was determined as described by Schweet (10). 
The determination of proline was carried out by this procedure (10) and 
by that of Troll and Lindsley (11). Because PY R-2-CA gives color under 
the conditions of these procedures, it was destroyed by treatment with 
hydrogen peroxide (2) as follows. Aliquots of 0.3 ml. containing 0.05 to 
0.25 pmole of proline and 0.05 to 2.0 Ltmoles of PYR-2-CA were treated with 
2 Cultures of the Neurospora were kindly donated by Dr. H. J. Vogel. 
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792 L-PIPECOLIC ACID AND L-PROLINE 
0.1 ml. of 0.2 M hydrogen peroxide. After 15 minutes, 0.1 ml. of a solution 
containing 50 units of crystalline catalase was added to destroy the per- 
oxide. The destruction of peroxide was complete within 15 minutes and 
the samples were then analyzed for proline. The recovery of proline in 
the presence of PYR-&CA was 98 to 100 per cent under the experimental 
conditions employed in these studies. 
TABLE I 
Reduction of Al-Piperidine-.9-Carboxylic Acid, A’-Pyrroline-d-Caarbozylic .4cid, and 
A’-Pyrroline-b-Catboxylic Acid by Several Rat Tissues 
Homogenates’ 
Tissue 
PIP-Z-CA PYR-Z-CA 
- 
Kidney..................... 18.2 22.8 
Brain....................... 10.7 14.4 
Liver....................... 4.26 6.71 
Testis....................... 4.16 6.56 
Heart. . . 1.93 2.80 
Skeletal muscle. 1.32 1.70 
Spleen. 0.615 1.07 
* The reaction mixtures consisted of 0.1 ml. of 
- 
I Centrifuged homogenatest - 
-- 
PIP-Z-CA PYR-Z-CA 
11.5 13.4 
5.94 7.90 
2.34 3.34 
1.95 3.18 
0.362 0.579 
0.355 0.444 
- 
homogenate gm. of 
- 
-- 
- 
frc 
PYR-S-CA 
0.0958 
1.58 
1.82 
1.82 
0.115 
1.07 
?sh tissue 
plus 2 ml. of 0.1 M potassium phosphate buffer of pH 7.0), 0.1 ml. of DPNH (4 pmoles) 
in phosphate buffer, and 0.1 ml. of PIP-2-CA or PYR-P-CA (2 amoles). The mix- 
tures were maintained at 37” for 10 to 60 minutes and subsequently analyzed for 
pipecolic acid or proline; the values are expressed as micromoles of imino acid formed 
enzymatically per hour per ml. of homogenate. 
f The reaction mixtures consisted of 0.05 ml. or 0.1 ml. of centrifuged homogenate 
(i.e. supernatant solut,ion after centrifugation at 144,000 X g for 2 hours in a Spinco 
model L centrifuge), DPNH (0.15 rmole), and PIP-2-CA (2 rmoles), PYR-P-CA (2 
rmoles), or DL-PYR-5-CA (4 pmoles) in a final volume of 1 .O ml. of 0.08 M potassium 
phosphate buffer of pH 6.1. The reaction was started by addition of substrate and 
the decrease in the absorption band at 340 rnr of DPNH was followed in a Cary re- 
cording spectrophotometer at 26”; values were calculated from t,he AD for the first 
60 to 180 seconds, and are expressed as micromoles of DPNH oxidized per hour per 
ml. of enzyme preparat,ion. 
Results 
Formation of Proline and Pipecolic Acid by Several Rat Tissues-Homo- 
genates of a number of rat tissues were incubated with PIP-2-CA, 
PYR-2-CA, or PYR-5-CA and DPNH. As indicated in Table I, all of 
the tissues examined were capable of reducing these substrates as deter- 
mined by the appearance of proline or pipecolic acid. Fra&ionations of 
liver and of kidney carried out by the procedure of Schneider and Hoge- 
boom (12) revealed that most of the enzyme activity remained in the super- 
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MEISTER, ItADHAKItIYHNAS, ANI) IIIJCKLEY i93 
natant fraction after high speed centrifugation. Studies with homogenates 
centrifuged at 144,000 X 9 for 2 hours were performed by means of a 
spectrophotometric technique which was based on the disappearance of 
the band at 340 rnp due to DPNH. In both sets of experiments the rela- 
tive rates of reduction of PYR-2-CA and PIP-2-CA were approximately 
the same. The ratios of the values for PYR-2-CA to those for PIP-2-CA 
were between 1.2 and 1.7. The values for the reduction of PYRd-CA 
were not according to the pattern observed with PIP-2-CA and PYR-2-CA. 
These studies indicate that the kidney is the most active tissue in catalyz- 
ing the reduction of PIP-2-CA and PYR-2-CA and suggest that the system 
TABLE II 
Substrate Specijicity of Liver and Kidney Preparations* 
Tissue preparation PYR-Z-CA PIP-Z-CA PYR-S-CA 
~-___-- __.~-- 
Liver 
_-~- .~. ..~~___~ .-.. .-..~ -. ~~~ .~~~ 
Homogenate.. .,_, .._ ., ..,__, 0.255 0.158 0.142 
Supernatant solution.. 0.765 0.481 0.412 
Ammonium sulfate fraction.. 7.23 4.18 2.61 
Final preparation. 9.10 5.91 1.99 
_- ___- 
Kidney 
- 
Homogenate. _..._............. 1.23 1.02 0.009 
Supernatant solution. 3.81 2.96 0.019 
Ammonium sulfate fraction 25.8 19.9 0.007 
Final preparation. , 74.1 59.4 <0.003 
* See the text for the description of tissue preparations. The values are expressed 
as micromoles of DPNH oxidized in the presence of substrate per mg. of protein 
nitrogen per hour at 26” as described in Table I. 
responsible for the reduction of PYR-5-CA is different from that which 
catalyzes reduction of PIP-2-CA and PYR-2-CA. 
Studies with Purified Liver and Kidney Preparations-Table II sum- 
marizes the values obtained for the reduction of PYR-2-CA, PIP-2-CA, 
and PYR-5-CA by liver and kidney fractions, prepared as described above, 
The purification procedure brought about a 36-fold increase in the specific 
activities of the liver preparation toward PYR-2-CA and PIP-2-CA; the 
activity with respect to PYRd-CA was increased 14-fold. A 60-fold 
purification was obtained with the kidney preparation for the activities 
responsible for the reduction of PYR-2-CA and PIP-2-CA; the activity of 
the kidney homogenate toward PYRd-CA was very low, and this activity 
could not be detected in the final preparation. 
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794 L-PIPECOLIC ACID AND L-PROLINE 
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FIQ. 1. A, time-course of the reduction of PYR-2-CA and PIP-P-CA by the puri- 
fied kidney enzyme preparation at 26’. The reaction mixtures consisted of 0.2 
rmole of PYR-2-CA (Curve 1) or PIP-O-CA (Curve 2), 0.25 pmole of DPNH, and 
enzyme (26 ‘y of protein nitrogen) in 0.15 ml. of 0.05 M potassium phosphate buffer, pH 
6.1. Samples were analyzed at intervals for proline (0) or pipecolic acid (0) and, 
after dilution to 1 ml., were read at 340 rnp for determination of DPNH. B, pH- 
activity curves. The reaction mixtures consisted of reduced pyridine nucleotide 
(0.15 &mole), keto acid (2 &moles) and enzyme in a final volume of 1 ml. of 0.08 M 
potassium phosphate buffer (0) or 0.08 M sodium acetate buffer (0); 26”. Ordi- 
nate, change in optical density at 340 rnp per minute. Curve 1, DPNH, PYR&CA, 
purified liver enzyme; Curve 2, DPNH, PYR-2-CA, purified kidney enzyme; Curve 
3, TPNH, PYR-P-CA, purified kidney enzyme; Curve 4, DPNH, PIP-2-CA, purified 
kidney enzyme. C, effect of keto acid concentration. The reaction mixtures con- 
sisted of DPNH or TPNH (0.15 rmole), keto acid as indicated, and purified kidney 
enzyme (13 y of protein nitrogen) in 1 ml. of 0.08 M potassium phosphate buffer, pH 
6.1; 26”. Curve 1, DPNH, PYR-2-CA; Curve 2, DPNH, PIP-2CA; Curve 3, TPNH, 
PIP-P-CA. Ordinate as in B. D, effect of nucleotide concentration. The reaction 
mixtures consisted of keto acid (2 #moles), nucleotide as indicated, and purified 
kidney enzyme (13 y of protein nitrogen) in 1 ml. of 0.08 M potassium phosphate buffer, 
pH 6.1; 26”. Ordinate as in B. Curve 1, DPNH, PYR-2-CA; Curve 2, DPNH, 
PIP-P-CA; Curve 3, TPNH, PIP-%-CA. E, reduction of PIP-P-CA to pipecolic acid 
coupled with oxidation of d-isocitrate by liver preparation (ammonium sulfate frac- 
tion). The reaction mixtures consisted of TPN (0.142 pmole), potassium d-isocitrate 
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MEISTER, RADHAKRISHNAN, AND BUCKLEY 795 
The time-course of the reduction of PYR-2-CA and PIP-2-CA by the 
purified kidney enzyme preparation is described in Fig. 1, A. Values for 
the disappearance of DPNH and the appearance of proline (or pipecolic 
acid) were in close agreement, and the reaction went to completion. The 
reduction of PYR-2-CA and of PIP-2-CA with both liver and kidney prep- 
arations exhibited a pH optimum of approximately 6. In contrast, the 
pH optimum for the reduction of PYR-5-CA was about 6.8. The pH 
optima were the same with DPNH and TPNH (Fig. 1, B). 
The effect of substrate and nucleotide concentration on the rate of re- 
duction was studied with the purified kidney enzyme (Fig. 1, C and D). 
The Michaelis constants for the reduction of PYR-2-CA (with DPNH), 
PIP-2-CA (with DPNH), and PIP-2-CA (with TPNH) were 8.6 X lo+ 
M, 6.0 X 1O-s M, and 12.4 X 10m6 M, respectively (Fig. 1, c). 
The Michaelis constants for DPNH (with PYR-2-CA), DPNH (with 
PIP-2-CA), and TPNH (with PIP-2-CA) were 4.27 X lo+ M, 7.4 X 10m5 
M, and 3.82 X 10-b M, respectively (Fig. 1, 0). These values are of ap- 
proximately the same order of magnitude and indicate a relatively high 
degree of affinity for both substrate and nucleotide. 
The reduction of PIP-2-CA to pipecolic acid was coupled with the oxi- 
dation of d-isocitrate by using the ammonium sulfate fraction obtained 
from liver. This fraction exhibited significant isocitric dehydrogenase 
activity in the presence of manganese ions. As indicated in Fig. 1, E, ap- 
preciable formation of pipecolic acid was observed in the presence of iso- 
citrate, PIP-2-CA, and a relatively small quantity of TPN. 
Both PIP-2-CA and PYR-2-CA were stoichiometrically reduced in the 
presence of reduced coenzyme (Fig. 1, F). Within experimental error, 
the decrease in the absorption at 340 rnp was equivalent to the quantity 
of substrate added. Attempts to demonstrate DPNH and TPNH for- 
mation from the corresponding oxidized coenzymes and proline (or pipe- 
colic acid) were not successful. 
(4 rmoles), PIP-2-CA (7.5 pmoles), MnClz (1 #mole) and liver fraction (100 y of pro- 
t*ein nitrogen) in a final volume of 0.06 ml. of 0.05 M potassium phosphate buffer, pH 
7.0; 37”. Ordinate, formation of pipecolic acid. X, value for an experiment carried 
out with 2 pmoles of d-isocitrate. F, Stoichiometric reduction of PIP-P-CA and 
PYR-2-CA by DPNH and TPNH. DPNH, the reaction vessel contained 0.056 
rmole of DPNH and 50 y of purified kidney enzyme protein nitrogen in 0.98 ml. of 
0.078 M potassium phosphate buffer, pH 6.1; 0.025 rmole of PYR-2-CA was added at 
Point 1; 0.025 rmole of PIP-P-CA was added at Point 2. TPN; the reaction vessel 
contained 0.12 rmole of TPN, 1 rmole of MnCl2, and liver enzyme preparation (am- 
monium sulfate fraction; 100 y of protein nitrogen) in 0.98 ml. of 0.078 M potassium 
phosphate buffer, pH 6.8; 0.06 pmole of d-isocitrate was added at point 3; 0.025 amole 
of PYR-2-CA was added at point 4; 0.025 rmole of PIP-P-CA was added at point 5; 
1 rmole of d-isocitrate was added at point 6. Ordinate, optical density at 340 mp 
(corrected for volume changes to 1.0 ml.); 26’. 
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7% L-PIPECOLIC ACID AND L-PROLINE 
The purified kidney preparation exhibited no activity with the following 
substrates: pyrrole-2-carboxylic acid, picolinic acid, 5-oxo-2-pyrrolidone- 
carboxylic acid, and A’-pyrroline-4-hydroxy-2-carboxylic acid. 
Studies with Plant Extracts-Preparations obtained from P. sativum 
and P. radiatus catalyzed conversion of PYR-2-CA and PIP-2-CA to pro- 
line and pipecolic acid, respectively, in the presence of DPNH. A detailed 
study of the plant tissues was not carried out; however, it was found that 
the activity of the plant extracts was of the same order of magnitude as 
that observed with rat liver homogenates. 
Studies with Microorganisms-As indicated in Table III, enzyme prep- 
arations obtained from a mutant of N. crassa blocked in biosynthesis of 
proline between PYRd-CA and proline (8), as well as enzyme preparations 
derived from the corresponding parent wild strain, catalyzed the reduction 
TABLE III 
Pormulion of Pipecolic Acid and Proline by Neurospora Preparations 
Source 
Growth response Enzymatic reduction* 
Proline PYR-2.CA PYR-S-CA PYR-2-CA PYR-S-CA PIP-2-CA 
Wild strain.. . 0.680 0.540 0.640 
Mutant. _. 106 65t 0 0.716 <O.Ol 0.700 
- -&-I ~--. 
* The reaction mixtures consisted of 2 rmoles of I’YR-2CA, PIP-P-CA, or 4 
rmoles of DL-PYR-5-C& 0.15rmole of DPNH, and 0.1 ml. of enzyme preparation in 
a final volume of 1.0 ml. of 0.067 M potassium phosphate buffer, pH 6.8; the values 
are given as micromoles of DPNH oxidized per hour at 26”. 
t Based on dry weight of mycelia formed relative to growth response to L-proline. 
of PYR-2-CA and PIP-2-CA. On the other hand, although the enzyme 
preparation obtained from the wild strain catalyzed significant reduction of 
PYRd-CA, no detectable conversion of PYR-5-CA to proline was observed 
with the mutant enzyme preparation (cf. Yura and Vogel (8)). It is of 
associated interest that the mutant strain exhibited a growth response to 
PYR-2-CA which was approximately 65 per cent of that observed with 
L-proline. 
Studies were also carried out with two proline-requiring auxotrophs of 
Escherichia wli with use of the medium of Davis and Mingioli (13). Mu- 
tant 55-l (3),a which is known to be blocked between PYR-5-CA and pro- 
line, did not grow on basal media supplemented with either PYR-ZCA or 
PYR-B-CA (2). Mutant 55-25, which is blocked prior to PYRd-CA in 
the biosynthetic sequence (3), exhibited a growth response to PYR-5-CA 
which was equivalent in magnitude to that observed with racemic proline, 
* The E. coli cultures were generously provided by Dr. B. D. Davis. 
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MEISTER, RADHAKRISHNAN, ANI) BUCKLEY 797 
but it did not grow on PYR-2-CA. A mutant of Aerobaetor aerogenes, 
isolated in this laboratory by the penicillin technique,4 appeared to be 
similar to E. coli mutant 55-25 in that it responded to either proline or 
PYRd-CA. However, in contrast to this E. coli mutant, the A. aerogenes 
mutant grew equally well when equimolar quantities of PYR-2-CA or of 
L-proline were present in the medium. 
Experiments were carried out with broken cell suspensions (prepared by 
sonic oscillation or by grinding with powdered glass) of the several strains 
of E. coli and A. aerogenes in an effort to determine whether these prepara- 
tions could catalyze the reduction of PYR-2-CA, PIP-2-CA, and 
PYRd-CA. Preparations obtained from the wild strains, E. coli mutant 
55-25 and the A. aerogenes mutant, catalyzed formation of proline from 
PYR-5-CA in the presence of DPNH, although E. coli mutant 55-l was 
not appreciably active. It is of interest that some proline was formed 
from PYR-5-CA in the absence of added DPNH, suggesting that reduced 
coenzyme was present in the preparation or possibly that another mecha- 
nism for the reduction of PYRd-CA exists. Although proline and pipe- 
colic acid were formed from PYR-2-CA and PIP-2-CA, respectively (in 
the presence of DPNH), with preparations of all of the bacteria, the rates 
of imino acid formation were not appreciably greater than those of the 
corresponding non-enzymatic reactions (see below). The observation 
that the A. aerogenes mutant exhibited a growth response to PYR-2-CA 
suggests that it can catalyze conversion of this compound to proline; 
failure to demonstrate this in crude cell preparations may possibly be 
ascribed to the relatively low activity of this enzyme system or to compet- 
ing reactions. 
Optical Configuration of Enzymatically Formed Proline and Pipecolic 
Acid-That the proline and pipecolic acid formed by enzymatic reduction 
of PYR-ZCA and PIP-2-CA, respectively, were of the L configuration was 
established by the failure of the enzymatically synthesized amino acids to 
undergo oxidation by purified n-amino acid oxidase, under conditions 
whereby 50 per cent of the corresponding racemic mixtures was destroyed. 
Reaction mixtures containing enzymatically formed pipecolic acid or 
proline were deproteinized by addition of 3 volumes of ethanol and the 
ethanol extracts were evaporated to dryness. The residues were treated 
with purified sheep kidney n-amino acid oxidase (14), FAD, and pyro- 
phosphate buffer, pH 8.3. The mixtures were shaken in air at 37” for 3 
hours. Analyses for proline and pipecolic acid were carried out before 
and after treatment with purified n-amino acid oxidase. There was no 
disappearance of imino acid under these conditions, although in control 
experiments with racemic proline and pipecolic acid there was a 50 per cent 
4 Isolated by Phyllis Fraser Downey. 
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798 L-PIPECOLIC ACID AND L-PHOLINE 
reduction in the concentration of imino acid. Although enzymatic re- 
duction of DL-PYRd-CA to proline has been demonstrated previously 
(8, 15, 16), there are apparently no published data on the configuration of 
the proline formed. Studies carried out with n-amino acid oxidase as 
described above indicated that the product of the reduction of UL-PYR-5- 
CA by preparations of liver and of E. coli is L-proline. In these experi- 
ments, it was necessary to separate the proline from PYRd-CA by chro- 
matography inasmuch as the latter compound interferes with the 
determination of proline by the procedures employed. 
Non-Enzymatic Formation of Proline and Pipecolic Acid-When 
PYR-S-CA and DPNH were incubated at 37” in the absence of an enzyme 
preparation, a relatively slow formation of proline was detected. Thus, 
0.187 rmole of proline was formed in a mixture consisting of 2 +noles of 
PYR-2-CA and 4 pmoles of DPNH in 0.3 ml. of 0.067 M potassium phos- 
phate buffer at pH 6.2, in 2 hours at 37”. A similar experiment with 
PIP-2-CA gave 0.065 pmole of pipecolic acid, whereas no proline was 
formed with PYR-5-CA. The non-enzymatic reaction took place most 
rapidly at pH values between 6.0 and 6.5. The proline formed in the 
absence of enzyme was shown to be racemic by the procedure described 
above. The non-enzymatic reaction did not take place at a measurable 
rate under the conditions employed in the spectrophotometric determina- 
tions. 
DISCUSSION 
The conversion of lysine to pipecolic acid has been demonstrated by 
isotope tracer experiments in plants (17-19) and in the intact rat (20). 
There is also evidence for the conversion of lysine to PIP-P-CA by enzy- 
matic oxidation (2,21). The finding that the cr-keto acid analogue of lysine 
exists in solution in equilibrium between cyclic and open chain forms (2) 
and the observation that the a-amino group rather than the e-amino group 
of lysine is lost in the conversion of lysine to pipecolic acid in the rat (20) 
suggest that PIP-2-CA is an intermediate between lysine and pipecolic 
acid. The present demonstration that PIP-2-CA is enzymatically re- 
duced to L-pipecolic acid by preparations of animal and plant tissues gives 
support to this hypothesis. That the reduction of PIP-2-CA to L-pipecolic 
acid proceeds to completion and our inability to demonstrate this reaction 
in the reverse direction suggest that the equilibrium of this reaction 
strongly favors pipecolic acid formation. These findings are consistent 
with observations which indicate that pipecolic acid cannot substitute for 
lysine in supporting the growth of rats (22) or Neurospora mutants (19). 
PYR-2-CA was reduced to proline by enzyme preparations obtained 
from rat tissues, higher plants, and Neurospora. Although present evi- 
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dence suggests that PYR-5-CA is an intermediate in the metabolism of 
proline in microorganisms and in mammalian tissues, it is possible that a 
pathway involving PYR-Z-CA also exists. The finding that strains of 
N. crassa and A. aerogenes, genetically blocked in the synthesis of proline, 
can utilize PYR-2-CA for growth is compatible with the existence of such 
an alternative metabolic pathway. 
The enzymatic data described here indicate that PYR-5-CA and PYR-2- 
CA are reduced by different enzymes. This conclusion is supported by 
the markedly different activities observed with preparations of various 
animal tissues (Table I) and also by studies on the purified rat kidney 
enzyme preparation, which exhibited no detectable activity toward 
PYR-5-CA (Table II). In addition, preparations of the N. crassa mutant 
exhibited no detectable activity toward PYR-5-CA, whereas both 
PYR-2-CA and PIP-2-CA were reduced. The present data also lead to 
the tentative conclusion that PIP-2-CA and PYR-2-CA are reduced by the 
same enzyme. 
SUMMARY 
1. Preparations from rat liver, kidney, spleen, testis, heart, skeletal 
muscle, and brain, in the presence of reduced diphosphopyridine nucleotide 
(DPNH), catalyze the reduction of A’-pyrroline-2-carboxylic acid and 
A’-pyrroline-5-carboxylic acid to proline; these preparations also catalyze 
the reduction of A’-piperidine-2-carboxylic acid to pipecolic acid. Ex- 
tracts of Pisum sativum and Phaseolus radiatus also reduce Al-piperidineS- 
carboxylic acid and Al-pyrroline-2-carboxylic acid to pipecolic acid and 
proline, respectively. 
2. A purified enzyme preparation was obtained from rat kidney that 
catalyzes the reduction of A’-pyrroline-2-carboxylic acid and Al-piperidine- 
2-carboxylic acid but not that of A’-pyrroline-5-carboxylic acid, picolinic 
acid, pyrrole-2-carboxylic acid, 5-oxo-2-pyrrolidonecarboxylic acid, or 
A’-pyrroline-4-hydroxy-2-carboxylic acid; the enzyme is active with both 
DPNH and reduced triphosphopyridine nucleotide (TPNH). The pH 
optima for the reactions and the Michaelis constants for the substrates 
and coenzymes have been determined. The reduction of A’-piperidine-2- 
carboxylic acid has been coupled wit.h the oxidation of isocitrate in t,he 
presence of TPN. 
3. Enzyme preparations obtained from a mutant strain of Neurospora 
crassa, genetically blocked in the reduction of A’-pyrroline-5-carboxylic 
acid to proline, and the corresponding parent wild strain catalyze the 
reduction of Al-pyrroline-2-carboxylic acid and A’-piperidine-2-carboxylic 
acid. The N. crassa mutant and a proline-requiring mutant of Aerobacter 
aerogenes exhibit a growth response to A’-pyrroline-2-carboxylic acid. 
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4. The imino acids formed by enzymatic reduction of Al-pyrrohne-2-car- 
boxylic acid, Al-piperidine-2-carboxylic acid, and Al-pyrroline-5-carboxylic 
acid have been shown to be of the L configuration. 
5. Non-enzymatic reduction of Al-pyrroline-2-carboxylic acid and 
A’-piperidine-2-carboxylic acid by DPNH has been observed; these reac- 
tions exhibit a pH optimum between 6.0 and 6.5. Under similar condi- 
tions, A’-pyrroline-5-carboxylic acid is not reduced. 
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